缩写名/全名 |
BLOOD
BLOOD |
||||||||||||||||||||||||||||
ISSN号 | 0006-4971 | ||||||||||||||||||||||||||||
研究方向 | 医学-血液学 | ||||||||||||||||||||||||||||
影响因子 | 2015:11.841, 2016:13.164, 2017:15.132, 2018:16.562, 2019:17.543, | ||||||||||||||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||||||||||||||
出版周期 | Semimonthly | ||||||||||||||||||||||||||||
年文章数 | 494 | ||||||||||||||||||||||||||||
出版年份 | 1946 | ||||||||||||||||||||||||||||
是否OA | No | ||||||||||||||||||||||||||||
审稿周期(仅供参考) | 平均1.0个月 |
||||||||||||||||||||||||||||
录用比例 | 较难 | ||||||||||||||||||||||||||||
投稿链接 | http://submit.bloodjournal.org/ | ||||||||||||||||||||||||||||
投稿官网 | http://bloodjournal.hematologylibrary.org/ | ||||||||||||||||||||||||||||
h-index | 426 | ||||||||||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0006-4971%5BISSN%5D | ||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy. Author: Kusumoto S1, Arcaini L2,3, Hong X4, Jin J5, Kim WS6, Kwong YL7, Peters MG8, Tanaka Y9, Zelenetz AD10,11, Kuriki H12, Fingerle-Rowson G13, Nielsen T13, Ueda E12, Piper-Lepoutre H13, Sellam G13, Tobinai K14. Journal: Blood. 2019 Jan 10;133(2):137-146. doi: 10.1182/blood-2018-04-848044. Epub 2018 Oct 19. PubMed DOI |
2. | The transmembrane protein disulfide isomerase TMX1 negatively regulates platelet responses. Author: Zhao Z1, Wu Y1,2, Zhou J1,2, Chen F1, Yang A1, Essex DW2. Journal: Blood. 2019 Jan 17;133(3):246-251. doi: 10.1182/blood-2018-04-844480. Epub 2018 Nov 13. PubMed DOI |
3. | BCAS2 is essential for hematopoietic stem and progenitor cell maintenance during zebrafish embryogenesis. Author: Yu S1, Jiang T1, Jia D1, Han Y1, Liu F1, Huang Y1, Qu Z1, Zhao Y2, Tu J1, Lv Y1, Li J1, Hu X1, Lu Z1, Han S1, Qin Y1, Liu X1, Xie S1, Wang QK1, Tang Z1, Luo D2,3, Liu M1. Journal: Blood. 2019 Feb 21;133(8):805-815. doi: 10.1182/blood-2018-09-876599. Epub 2018 Nov 27. PubMed DOI |
4. | Novel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in Hispanics. Author: Qian M1,2,3, Xu H4, Perez-Andreu V1,5, Roberts KG6, Zhang H1,7, Yang W1, Zhang S4, Zhao X1, Smith C1, Devidas M8, Gastier-Foster JM9,10,11, Raetz E12, Larsen E13, Burchard EG14, Winick N15, Bowman WP16, Martin PL17, Borowitz M18, Wood B19, Antillon-Klussmann F20, Pui CH21,22, Mullighan CG6,22, Evans WE1,22, Hunger SP23,24, Relling MV1,22, Loh ML25,26, Yang JJ1,21,22. Journal: Blood. 2019 Feb 14;133(7):724-729. doi: 10.1182/blood-2018-07-862946. Epub 2018 Dec 3. PubMed DOI |
5. | Low-dose chidamide restores immune tolerance in ITP in mice and humans. Author: Zhao HY1,2, Ma YH1,3, Li DQ2, Sun T1, Li LZ1, Li P1,4, Liu XG1, Zhou H1, Hou Y1, Liu Y1, Han PP1, Zhao YJ1, Jing FM1, Peng J1,5, Hou M1,5,6,7. Journal: Blood. 2019 Feb 14;133(7):730-742. doi: 10.1182/blood-2018-05-847624. Epub 2018 Dec 14. PubMed DOI |
6. | Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. Author: Klanova M1,2,3, Sehn LH4, Bence-Bruckler I5, Cavallo F6, Jin J7, Martelli M8, Stewart D9, Vitolo U10, Zaja F11, Zhang Q12, Mattiello F13, Sellam G3, Punnoose EA14, Szafer-Glusman E14, Bolen CR15, Oestergaard MZ16, Fingerle-Rowson GR3, Nielsen T3, Trneny M1. Journal: Blood. 2019 Feb 28;133(9):919-926. doi: 10.1182/blood-2018-07-862862. Epub 2019 Jan 7. PubMed DOI |
7. | Editing aberrant splice sites efficiently restores β-globin expression in β-thalassemia. Author: Xu S1,2,3,4,5,6, Luk K7, Yao Q1,2,3,4,5,8,9,10,11, Shen AH1,2,3,4,5, Zeng J1,2,3,4,5, Wu Y1,2,3,4,5,12,13,14, Luo HY15,16,17, Brendel C1,2,3,18, Pinello L4,8,9,10,11, Chui DHK15,16,17, Wolfe SA7,19, Bauer DE1,2,3,4,5. Journal: Blood. 2019 May 23;133(21):2255-2262. doi: 10.1182/blood-2019-01-895094. Epub 2019 Jan 31. PubMed DOI |
8. | Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma. Author: Zhuang J1,2, Shirazi F2, Singh RK2, Kuiatse I2, Wang H2, Lee HC2, Berkova Z2, Berger A3, Hyer M3, Chattopadhyay N3, Syed S3, Shi JQ3, Yu J3, Shinde V3, Tirrell S3, Jones RJ2, Wang Z2, Davis RE2, Orlowski RZ2,4. Journal: Blood. 2019 Apr 4;133(14):1572-1584. doi: 10.1182/blood-2018-06-859686. Epub 2019 Feb 8. PubMed DOI |
9. | Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease. Author: Zhang L1, Zhao AL1, Duan MH1, Li ZY2, Cao XX1, Feng J1, Zhou DB1, Zhong DR2,3, Fajgenbaum DC4, Li J1. Journal: Blood. 2019 Apr 18;133(16):1720-1728. doi: 10.1182/blood-2018-11-884577. Epub 2019 Feb 13. PubMed DOI |
10. | Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Author: Sanz MA1,2,3, Fenaux P4,5, Tallman MS6, Estey EH7, Löwenberg B8, Naoe T9, Lengfelder E10, Döhner H11, Burnett AK12, Chen SJ13, Mathews V14, Iland H15, Rego E16,17, Kantarjian H18, Adès L4,5, Avvisati G19, Montesinos P1,3, Platzbecker U20, Ravandi F18, Russell NH21, Lo-Coco F22. Journal: Blood. 2019 Apr 11;133(15):1630-1643. doi: 10.1182/blood-2019-01-894980. Epub 2019 Feb 25. PubMed DOI |
|
|